Stella

4888.T

Tags: JP Healthcare Biotechnology

Stella Pharma Corporation Price (4888.T)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

30,975,307

(7.2657)%

Market Cap of Stella (4888.T)

Market cap:

As of , 4888.T has a market cap of . This makes 4888.T the 1870th most valuable company in the JP by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $260-602
Market Cap 13.92B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Mr. Koki Uehara
IPO Date: April, 22, 2021
Country: JP
Currency: JPY
Headquaters: No Data
Employees: 44

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: